1. Home
  2. Events

Events

Search Language

italiano / Italian | Use language selector above (below, on mobile) to search additional languages

Open filter
  • Selected filters
  • x(professional development)
  • x(Start: March.01.2022)
  • x(End: December.31.2022)
  • clear all

33 items matching filters

Events

Founder Legal Boot Camp #3

November.12.2022 - November.13.2022 | Orrick Düsseldorf or Remote via Zoom

The third edition of Orrick’s Founder Legal Boot Camp – together with RWTH Innovation, WHU Entrepreneurship Center and TUM Venture Labs.

Events

A Word About Wind’s 2022 Financing Wind North America Conference

November.02.2022 | Convene

Orrick is proud to sponsor A Word About Wind’s 2022 Financing Wind North America Conference, where Blake Winburne will moderate the “Offshore Wind: Is the Momentum now Unstoppable?” panel discussion on opportunities and challenges for the U.S. offshore wind sector and building a robust supply ...

Events

Privacy + Security Forum Fall Academy

November.02.2022 - November.04.2022 | George Washington University Student Center

Members of Orrick’s Cyber, Privacy & Data Innovation Group are leading panels on privacy for children and teens in the United States (U.S.) and online safety in the United Kingdom (UK) during the Privacy + Security Forum Fall Academy hosted by the Privacy + Security Academy. The Privacy + Security ...

Events

International Bar Association Annual Conference 2022

October.30.2022 - November.04.2022 | Miami Beach Conventions Center | Miami, FL

James Parkinson drew upon his compliance and enforcement experience to discuss key anti-corruption developments from the past 12 months, and their impact on the legal and enforcement landscape.

Events

Are there still opportunities in China and Asia for US biopharmas?

October.19.2022 | Orrick New York

China is the second largest pharmaceutical market in the world, growing to $205bn by 2026. With an increasing focus on innovation and early access, many US biopharmas have found that an anchor in China supports accelerated clinical development and creates incremental value via either through equity ...